Israel - English - Ministry of Health

takeda israel ltd - albumin human - solution for infusion - albumin human 50 mg / 1 ml - albumin - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate.

Malta - English - Medicines Authority

biotest pharma gmbh landsteinerstrasse 5, 63303 dreieich, germany - albumin, human - solution for infusion - albumin, human 10 % (w/v) - immune sera and immunoglobulins

Malta - English - Medicines Authority

baxter healthcare limited - albumin, human 200 g/l - solution for infusion

Malta - English - Medicines Authority

baxter healthcare limited - albumin, human 50 g/l - solution for infusion

Singapore - English - HSA (Health Sciences Authority)

takeda pharmaceuticals (asia pacific) pte. ltd. - albumin (human) - injection, solution - 20g/100ml - albumin (human) 20g/100ml

Singapore - English - HSA (Health Sciences Authority)

takeda pharmaceuticals (asia pacific) pte. ltd. - albumin (human) - injection, solution - 25 g/100 ml - albumin (human) 25 g/100 ml

United States - English - NLM (National Library of Medicine)

octapharma usa inc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin (human) 200 g in 1000 ml - albumin (human) 20% is indicated in the emergency treatment of hypovolemia with or without shock. its effectiveness in reversing hypovolemia depends largely upon its ability to draw interstitial fluid into the circulation. it is most effective in patients who are well hydrated. when blood volume deficit is the result of hemorrhage, compatible red blood cells or whole blood should be administered as quickly as possible. [ 1 , 2 ] when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% - 25% albumin solutions should be used. [ 1 ] for subjects with hypoalbuminemia who are critically ill and/or are bleeding actively, albumin (human) 20% infusions may be indicated. [ 3 ] when albumin deficit is the result of excessive protein loss, the effect of administration of albumin (human) 20% will be temporary unless the underlying disorder is reversed. albumin (human) 20% may be used to maintain cardiovascular function following the removal of large volumes of ascitic f

United States - English - NLM (National Library of Medicine)

octapharma usa inc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin (human) 250 g in 1000 ml - albumin (human) 25% is indicated in the emergency treatment of hypovolemia with or without shock. its effectiveness in reversing hypovolemia depends largely upon its ability to draw interstitial fluid into the circulation. it is most effective in patients who are well hydrated. when blood volume deficit is the result of hemorrhage, compatible red blood cells or whole blood should be administered as quickly as possible. [ 1 , 2 ] when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% - 25% albumin solutions should be used. [ 1 ] for subjects with hypoalbuminemia who are critically ill and/or are bleeding actively, albumin (human) 25% infusions may be indicated. [ 3 ] when albumin deficit is the result of excessive protein loss, the effect of administration of albumin (human) 25% will be temporary unless the underlying disorder is reversed. albumin (human) 25% may be used to maintain cardiovascular function following the removal of large volumes of ascitic

United States - English - NLM (National Library of Medicine)

octapharma usa inc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin (human) 50 g in 1000 ml - albumin (human) 5% is indicated in the emergency treatment of hypovolemia with or without shock. its effectiveness in reversing hypovolemia depends largely upon its ability to draw interstitial fluid into the circulation. it is most effective in patients who are well hydrated. when blood volume deficit is the result of hemorrhage, compatible red blood cells or whole blood should be administered as quickly as possible. [ 1 , 2 ] albumin (human) 5% should be used when hydration is not adequate. when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% - 25% albumin solutions should be used. [ 1 ] for subjects with hypoalbuminemia who are critically ill and/or are bleeding actively, albumin (human) 5% infusions may be indicated.[ 3 ] when albumin deficit is the result of excessive protein loss, the effect of administration of albumin (human) 5% will be temporary unless the underlying disorder is reversed. albumin (human) 5% may be used to maintain cardiovascular

United States - English - NLM (National Library of Medicine)

octapharma pharmazeutika produktionsgesellschaft m.b.h. - albumin (human) (unii: zif514rvzr) (albumin (human) - unii:zif514rvzr) - albumin (human) 50 g in 1000 ml - albumin (human) 5% is indicated in the emergency treatment of hypovolemia with or without shock. its effectiveness in reversing hypovolemia depends largely upon its ability to draw interstitial fluid into the circulation. it is most effective in patients who are well hydrated. when blood volume deficit is the result of hemorrhage, compatible red blood cells or whole blood should be administered as quickly as possible. [1, 2] albumin (human) 5% should be used when hydration is not adequate. when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% - 25% albumin solutions should be used. [ 1 ] for subjects with hypoalbuminemia who are critically ill and/or are bleeding actively, albumin (human) 5% infusions may be indicated.[ 3 ] when albumin deficit is the result of excessive protein loss, the effect of administration of albumin (human) 5% will be temporary unless the underlying disorder is reversed. albumin (human) 5% may be used to maintain cardiovascular fu